Sebastiana Nervegna, Menander in Antiquity. The Contexts of Reception

Dans cet ouvrage inscrit dans le domaine des études de la réception, l’auteur interroge les causes de la notoriété posthume de Ménandre dans le monde hellénistique et romain. Nervegna montre comment l’athénien est devenu un auteur canonique, synonyme de la « Nouvelle comédie » et icône culturelle. En tentant d’expliquer cet engouement, l’auteur explore des sources aussi variées que riches : les comédies de Ménandre, les études qui lui ont été consacrées dans l’Antiquité et l’iconographie réun..

Inequality, Economic Growth and Trade Openness: a Case Study for Central and Eastern European Countries (ECE)

The paper analyzes the phenomenon of income inequality in ten countries from Eastern and Central Europe (ECE), by highlighting two aspects: (1) the link between growth and income inequality; (2) the effects of trade openess and other key factors on income inequality, such as: foreign direct investment (FDI), market capitalization and educational level of labour force. The method used was the Panel Data Analysis with statistical data from the period of 2000-2014. An increasing effect in income inequality was identified due to the trade openess, the inward stock of ISD and the market capitalization and an equalizing effect in the income distribution generated by the educational level of labour force. A positive association was also found between the growth of PIB per capita level and the increase of income inequality in the examined countries

Pierre Sylvain Filliozat, Michel Zink, Sourires d’Orient et d’Occident

Issu d’une journée d’études dans le cadre des réunions conjointes de la Compagnie du quai de Conti et de la Société asiatique, cet ouvrage réunit des contributions relevant de domaines divers : linguistique, études judaïques, bouddhisme et jainisme, iconographie khmère, grecque ou médiévale, littérature sanskrite et statuaire indien. Les huit communications se concentrent sur l’interrogation des multiples déclinaisons du sens du sourire ainsi que de son usage culturel dans l’Orient et l’Occid..

A brief review of the literature on the malignant ureteral obstruction

Malignant ureteral obstruction (MUO) caused by a primarily urological tumor or secondary to a late-stage malignancy can be difficult for the urologist to manage. Due to a lack of clinical data on the management of MUO, every case is particular and should be aborted individually. Lack of specific treatment, either palliative or definitive, can severely damage renal function and lifetime expectancy in patients, causing even more damage that could otherwise be avoided. Prompt management directed at the recovery of renal function is the main goal in such cases. Even after urinary flow is restored, life threatening post-obstructive diuresis needs to be managed

The importance of early arthritis in patients with rheumatoid arthritis

Rheumatoid arthritis (RA) is a systemic inflammatory disorder that manifests predominantly in the synovial joint, where it causes a chronic inflammatory process, leading to early osteoarticular destructions. These destructions are progressive and irreversible, generating a significant functional deficiency. During the last years, the diagnostic approach of RA has focused on early arthritis. Early arthritis can develop into established RA or another established arthropathy, like systemic lupus erythematosus or psoriatic arthritis. It can have a spontaneous resolution or may remain undifferentiated for indefinite periods of time. The management of early arthritis has changed considerably in the past few years, under the influence of new concepts of diagnosis and new effective therapies. The treatment goal of early arthritis should now be the clinical remission and prevention of joint destruction. Methotrexate is the first line of therapy, used to treat early arthralgia and to reverse or limit impending exacerbation to RA. Biological treatment is used as a second line therapy in patients with severe disease who do not respond or have a contraindication to disease-modifying antirheumatic drugs (DMARDs). Patients with early arthritis should usually be identified and directed to rheumatologists to confirm the presence of arthritis, and to establish the correct diagnosis plus to initiate the proper treatment strategies

Iron and manganese removal from drinking water

The purpose of the present study is to find a suitable method for removal of iron and manganese from ground water, considering both local economical and environmental aspects. Ground water is a highly important source of drinking water in Romania. Ground water is naturally pure from bacteria at a 25 m depth or more. However, solved metals may occur and if the levels are too high, the water is not drinkable. Different processes, such as electrochemical and combined electrochemical-adsorption methods have been applied to determine metals content in accordance to reports of National Water Agency from Romania (ANAR). Every water source contains dissolved or particulate compounds. The concentrations of these compounds can affect health, productivity, compliance requirements, or serviceability and cannot be economically removed by conventional filtration means. In this study, we made a comparison between the electrochemical and adsorption methods (using membranes). Both methods have been used to evaluate the efficiency of iron and manganese removal at various times and temperatures. We used two membrane types: composite and cellulose, respectively. Different approaches, including lowering the initial current density and increasing the initial pH were applied. Reaction kinetics was achieved using mathematical models: Jura and Temkin

New oral anticoagulants and their reversal agents

Atrial fibrillation is a commonly encountered pathology in medical practice, and its prevalence has shown a continuous rise over the past years. Atrial fibrillation has a significant impact on patients\u27 quality of life, not only due to the standard anticoagulant treatment with vitamin K antagonists that require close monitoring and dose adjustment, but also due to the fragile equilibrium between hemorrhagic and thrombotic risks. The introduction of new oral anticoagulants (NOACs) in the treatment guidelines for atrial fibrillation has improved the quality of life, as NOACs do not require close monitoring or dose adjustments. However, even if the safety profile of the NOACs regarding the hemorrhagic risk is superior to vitamin K antagonists, the problem raised by an unexpected hemorrhage (e.g. severe hemorrhage after an accident) and the need for efficient hemostasis in a chronic anticoagulated patient has remained unsolved. To find a solution for this problem, reversal agents for NOACs have been developed and tested, and two of them, idarucizumab and andexanet-alpha, have already been approved by the FDA, thus making NOACs increasingly appealing as a choice of anticoagulation treatment